# Glastad Invest

> Glastad Invest is a VC fund in Farsund backing Health Care, Biotechnology and Clinical Trials. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Farsund, Norway
- Total investments: 1
- Last investment: Nov 2007
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.glastad.no

Glastad Invest is a VC fund in Farsund focused on Health Care and Biotechnology. Glastad Holding is a family-owned company whose roots can be traced back to the shipping industry in the early 20th century. Today, Glastad Holding is a thriving investment company with three subsidiaries: Glastad Farsund - real estate, Mosvolds Rederi - shipping, and Glastad Invest - private equity and listed investments. Glastad Holding aims toexert active and long term ownership.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Clinical Trials | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SantoSolve | SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment. | $7M |  | Nov 07, 2007 |  |

1 of 1 investments shown.

## Co-investors
- [DNB](https://shizune.co/investors/profile/dnb-nor) — VC Fund, 1 deal together
- [Gezina](https://shizune.co/investors/profile/gezina) — VC Fund, 1 deal together
- [Innovations Kapital](https://shizune.co/investors/profile/innovations-kapital) — VC Fund, 1 deal together
- [Teknoinvest](https://shizune.co/investors/profile/teknoinvest) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Investinor](https://shizune.co/investors/profile/investinor) — VC Fund
- [Skyfall Ventures](https://shizune.co/investors/profile/skyfall-ventures) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Norway](https://shizune.co/investors/biotechnology-investors-norway)
- [Biotechnology VC Funds in Norway](https://shizune.co/investors/biotechnology-vc-funds-norway)
- [Health Care VC Funds in Norway](https://shizune.co/investors/health-care-vc-funds-norway)
- [Biotech Investors in Norway](https://shizune.co/investors/biotech-investors-norway)
- [Biotech VC Funds in Norway](https://shizune.co/investors/biotech-vc-funds-norway)

## FAQ

### What does Glastad Invest invest in?

Glastad Invest invests primarily in Health Care, Biotechnology and Clinical Trials startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Glastad Invest last invest?

The most recent investment recorded for Glastad Invest closed in Nov 2007. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co